Cycurion, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| For the Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets: | ||
| Cash and cash equivalents | $5,255,235 | $38,742 |
| Restricted cash | - | 2,048 |
| Accounts receivable, net | 2,687,479 | 10,353,708 |
| Other receivables | - | 434,391 |
| Prepaid expenses and other current assets | 60,133 | 99,463 |
| Total current assets | 8,002,847 | 10,928,352 |
| Deposit for acquisition target | - | 2,000,000 |
| Property and equipment, net | - | 20,321 |
| Software development costs, net | 4,606,981 | 4,151,981 |
| Intangible assets, net | - | 25,000 |
| Security deposits | - | 10,351 |
| Goodwill | 20,842,508 | 6,592,304 |
| Investments held in trust account | - | 1,834,540 |
| Total non-current assets | 25,449,489 | 14,634,497 |
| Total Assets | $33,452,336 | $25,562,849 |
| Liabilities, Mezzanine and Stockholders' Equity: | ||
| Bank loan-revolving credit line | $2,933,396 | $3,249,067 |
| Bank loan - current portion | - | 774,095 |
| Loans payable - current portion | 669,693 | 408,516 |
| Factoring liability | 1,511,678 | - |
| Subordinated convertible promissory notes | - | 3,333,335 |
| Convertible notes | 192,897 | - |
| Promissory notes | 2,499,662 | 2,486,989 |
| Loans payable - related parties | 123,650 | 148,088 |
| Accounts payable | 1,314,772 | 1,681,774 |
| Accrued liabilities | 4,228,337 | 2,927,135 |
| Accrued compensation and benefits | 919,825 | 979,684 |
| Accrued interest payable | 1,347,787 | 1,591,023 |
| Excise tax payable | 1,167,173 | 1,157,161 |
| Total current liabilities | 16,908,870 | 18,736,867 |
| Loans payable - non-current portion | 300,000 | 146,798 |
| Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively) | - | 1,294,117 |
| Total non-current liabilities | 300,000 | 1,440,915 |
| Total Liabilities | 17,208,870 | 20,177,782 |
| Commitments and contingencies (Note 22) | ||
| Mezzanine Equity: | ||
| Common stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively | - | 1,917,309 |
| Stockholders' Equity: | ||
| Preferred stock ($0.0001 par value, 20,000,000 shares authorized) | ||
| Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively) | - | - |
| Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 4,851 issued and outstanding) | - | - |
| Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding, respectively) | 15 | - |
| Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 0 issued and outstanding, respectively) | - | - |
| Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 143 and 0 issued and outstanding, respectively) | ||
| Common stock ($0.0001 par value, 300,000,000 shares authorized, 3,642,501 and 391,373 shares issued and outstanding, respectively) | 364 | 38 |
| Additional paid in capital | 46,979,762 | 6,671,081 |
| Accumulated deficit | (26,879,081) | (3,203,361) |
| Total stockholders' equity attributable to Cycurion | 20,101,060 | 3,467,758 |
| Deficit attributable to noncontrolling interests | (3,857,594) | - |
| Total stockholders' equity | 16,243,466 | 3,467,758 |
| Total liabilities and stockholders’ equity | $33,452,336 | $25,562,849 |
| See accompanying notes to consolidated financial statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.